Breast shields better at reducing dose than posteriorly centered partial CT, study finds

The use of breast shields is the technique of choice to protect the breasts of women from radiation exposure while undergoing chest CT examinations, according to a new study.

The use of CT has grown exponentially which brings into question the level of radiation exposure to patients. Recently the International Commission of Radiation Protection (ICRP) increased the tissue weighting factor for the breast from 0.05 to 0.1 noting that is even more sensitive to than previously thought, said Rafel Tappouni, MD, the lead author of the study. To put the risk into perspective, the delivery of 1 rad to a 35 old woman is estimated to increase her lifetime risk of by 13.6%; each CT exam delivers at least twice that amount, he said.
.

Dr. Tappouni and his colleagues at Penn State Hershey Medical Center in Hershey, PA measured the to the front and back of a breast phantom (a object that mimics the size of the breast area of a person) using a breast shield and using a new technique called posteriorly-centered partial CT. In posteriorly centered partial CT, the turns on and off as it scans the patient. "We found that posteriorly centered partial CT does decrease skin entrance radiation dose to the breast by 16%, but increases overall radiation dose to the chest by 8%," said Dr. Tappouni. "The bismuth breast shields, on the other hand, reduced skin entrance dose to the breast by 38% without an increase in overall radiation dose," he said.

Dr. Tappouni noted that they now use breast shields at his facility for all female patients up to age 90 who undergo chest CT examinations.

More information: The study is being presented during the American Roentgen Ray Society Annual Meeting on May 4 in Chicago.

Provided by American Roentgen Ray Society

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Bone loss drugs may help prevent endometrial cancer

1 hour ago

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...

Putting the brakes on cancer

Dec 19, 2014

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.